Micellar solubilization of some poorly soluble antidiabetic drugs: A technical note

AAPS PharmSciTech

Volumn 9, Issue 2, 2008, Pages 431-436

  Seedher, Neelam ^a   Kanojia, Mamta ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Antidiabetic drugs; Solubility; Surfactants

Indexed keywords

ANIONIC SURFACTANT; ANTIDIABETIC AGENT; BUFFER; CATIONIC SURFACTANT; GLIBENCLAMIDE; GLICLAZIDE; GLIMEPIRIDE; GLIPIZIDE; GLITAZONE DERIVATIVE; NONIONIC SURFACTANT; PIOGLITAZONE; REPAGLINIDE; ROSIGLITAZONE; SULFONYLUREA DERIVATIVE; SURFACTANT;

ARTICLE; CONTROLLED STUDY; DRUG SOLUBILITY; HYDROPHOBICITY; MICELLE; PH; PHYSICAL CHEMISTRY; THERMODYNAMICS; ULTRAVIOLET SPECTROSCOPY; CHEMICAL MODEL; CHEMISTRY; METHODOLOGY; PHARMACEUTICS; SOLUBILITY;

BUFFERS; CHEMISTRY, PHARMACEUTICAL; HYDROGEN-ION CONCENTRATION; HYPOGLYCEMIC AGENTS; MICELLES; MODELS, CHEMICAL; SOLUBILITY; SURFACE-ACTIVE AGENTS; TECHNOLOGY, PHARMACEUTICAL;

EID: 51449095969     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-008-9057-5     Document Type: Article

References (26)

1. M. A. Etman, R. O. Salama, M. A. Shamsedeen, and A. El-Kamel. Solubilization of etodolac for parenteral administration. Indian J. Pharm. Sci. 63: 459-467 (2001).
2. P. Li, L. Zhao, and S. H. Yalkowsky. Combined effect of cosolvent and cyclodextrin on solubilization of nonpolar drugs. J. Pharm. Sci. 88: 967-969 (1999).
3. P. M. Bhatt, N. V. Ravindra, R. Banerjee, and G. R. Desiraju. Saccharin as a salt former. Enhanced solubilities of saccharinates of active pharmaceutical ingredients. Chem. Commun. 8: 1073-1075 (2005).
4. A. B. Nielsen, K. Frydenvang, T. Liljefors, A. Buur, and C. Larsen. Assessment of the combined approach of N-alkylation and salt formation to enhance aqueous solubility of tertiary amines using bupivacaine as a model drug. Eur. J. Pharm Sci. 24: 85-93 (2005).
5. M. Otsuka, and Y. Matsuda. Effect of cogrinding with various kinds of surfactants on the dissolution behaviour of phenytoin. J. Pharm. Sci. 84: 1434-1437 (1995).
6. N. K. Kumar, M. B. G. V. Murali, C. D. S. Prasad, K. Himasankar, H. A. Seshasayana, and V. R. Murthy. Comparative studies on the effect of some hydrophilic polymers on the dissolution rate of a poorly water-soluble drug meloxicam. Indian Drugs. 39 (6):323-329 (2002).
7. M. P. Corvi, M. Cirri, and B. Allolio. Enhancement of solubility and bioavailability by ternary complexation with β-cyclodextrin and glycine. J. Pharm. Sci. 92: 2177-2184 (2003).
8. K. Uekama, T. Fujinaga, F. Hirayama, M. Otagiri, M. Yamasaki, H. Seo, T. Hashimoto, and M. Tsuruoka. Improvement of the oral bioavailability of digitalis glycosides by cyclodextrin complexation. J. Pharm. Sci. 72: 1338-1341 (1983).
9. P. Gupta, V. K. Kakamanu, and A. K. Bansal. Stability and solubility of Celecoxib-PVP Amorphous Dispersions: A Molecular Perspective. Pharm. Res. 21: 1762-1769 (2004).
10. C. Chauchan, S. Shimpi, and A. Paradkar. Preparation and characterization of etoricoxib solid dispersions using lipid carriers by spray drying technique. AAPS PharmaSciTech. 6: 50 (2005).
11. R. N. Saha, C. Sajeev, P. K. Padma, C. Sreekhar, and G. Shashikanth. Solubility enhancement of Nimesulide and ibuprofen by solid dispersion technique. Indian J. Pharm. Sci. 64: 529-534 (2002).
12. K. G. H. Desai, A. R. Kulkarni, and T. M. Aminabhavi. Solubility of rofecoxib in the presence of methanol, ethanol and sodium lauryl sulfate at (298.15, 303.15 and 308.15 K). J. Chem. Eng. Data. 48: 942-945 (2003).
13. C. Liu, K. G. H. Desai, and C. Liu. Solubility of valdecoxib in the presence of Ethanol and Sodium lauryl sulfate at (298.15, 303.15 and 308.15) K. J. Chem. Eng. Data. 49: 1847-1850 (2004).
14. K. G. H. Desai, and H. J. Park. Solubility studies of valdecoxib in the presence of carriers, cosolvents and surfactants. Drug Dev. Res. 62: 41-48 (2004).
15. C. O. Rangel-Yagui, A. Pessoa Jr, and L. C. Tavares. Micellar solubilization of drugs. J Pharm Pharmaceu Sci. 8: 147-163 (2005).
16. C. O. Rangel-Yagui, H. W. L. Hsu, A. Pessoa Jr, and L. C. Tavares. Micellar solubilization of ibuprofen - influence of surfactant head groups on the extent of solubilization. Brazilian J Pharm Sci. 41: 237-246 (2005).
17. D. Attwood, and A. T. Florence. Surfactant Systems: The Chemistry, Pharmacy and Biology, Chapman and Hall, New York, 1983.
18. M. Valleri, P. Mura, F. Maestrelli, M. Cirri, and R. Ballerini. Development and evaluation of glyburide fast developing tablets using solid dispersion technique. Drug Dev. Ind. Pharm. 30: 525-534 (2004).
19. H. O. Ammar, H. A. Salama, M. Ghorab, and A. A. Mahmoud. Implication of inclusion complexation of glimepiride in cyclodextrin-polymer systems on its dissolution, stability and therapeutic efficacy. Int. J. Pharm. 320: 53-57 (2006).
20. M. J. Arias-Blanco, J. R. Moyano, J. I. Perez-Martinez, and J. M. Gines. Study of the inclusion of gliclazide in a-cyclodextrin. J. Pharm. Biomed. Anal. 18: 275-279 (1998).
21. J. R. Moyano, M. J. Arias-Blanco, J. M. Gines, and F. Giordano. Study of the complexation behaviour of gliclazide with partially methylated β-cyclodextrin in solution and solid state. Int. J Pharm. 239: 243 (1997).
22. K. A. Alkhamis, H. Allaboun, and W. Y. AL-Momani. Study of the solubilization of gliclazide by aqueous micellar solutions. J. Pharm. Sci. 92: 839-846 (2003).
23. M. A. El-massik, I. A. Darwish, E. E. Hassan, and L. K. El-Khordagui. Development of a dissolution medium for glibenclamide. Int. J. Pharm. 140: 69-76 (1996).
24. A. T. Florence, and D. Attwood. Physicochemical Principles of Pharmacy, 3rd ed., Macmillan, London, UK, 1998, pp. 159-160, 230-232.
25. S. Paria. The mixing behaviour of n-alkylpyridinium bromide-NP-9 mixed surfactant systems. Colloid Surf. A. 281: 113-118 (2006).
26. L. Z. Zhu, L. Zhu, F. Shaoliang, and S. L. Feng. Synergistic solubilization of polycyclic aromatic hydrocarbons by mixed ionic-non-ionic surfactants. Chemosphere. 53: 459-467 (2003).